The ionic partition diagram methodology has been generalized to address both hydrophilic and lipophilic compounds and to consider biphasic systems with variable phase volume ratios. With this ...

But they were on the logs which was a part of the “Phase I” drop from Bondi. PEOPLE said Trump was listed on page 24 of the first flight log which was dated Oct. 11, ...

Claudin-18 isoform 2 (CLDN18.2) has emerged as a promising therapeutic target in gastric or gastro-oesophageal junction cancer. Satricabtagene autoleucel (satri-cel; also known as CT041), an ...

Methods: NIVOPOSTOP is an international randomized, open-label Phase 3 trial (NCT03576417). Main inclusion criteria were patients < 75 years, ECOG PS 0-1, with resected LA-SCCHN of the oral cavity, ...

Moonlake is running phase 3 studies of the nanobody in psoriatic arthritis and advancing the drug candidate toward pivotal trials in psoriasis, palmoplantar pustulosis and axial spondyloarthritis.

The KT-621 Phase Ib trial in moderate and severe AD is actively recruiting with data expected in Q4 of 2025. Additionally, two parallel Phase IIb trials in AD and asthma are planned to start in Q4 ...

Phase III data presented at ASCO 2025 and published in The New England Journal of Medicine show that Pfizer’s Braftovi (encorafenib), combined with Erbitux (cetuximab) and mFOLFOX6, significantly ...

The Next Phase of New York City’s ‘Trash Revolution’ Is Here Large residential buildings in West Harlem are now required to put trash in large bins on the street instead of in piles on the curb.

Half of the moon will be illuminated as it reaches its first quarter phase on Monday, June 2. The first quarter phase marks the quarter point on the moon's monthly journey, according to NASA .

Allogene Therapeutics, Inc. Data Highlights Transformative Promise of CAR T in Solid Tumors. Phase 1 Trial with ALLO-316 Demonstrated Potential to Provide Meaningful Clinical Benefit in Patients ...

- 4 of 11 PDAC patients in the pilot phase remained progression free at over one year - Poster presentation on Saturday, May 31 st. TEL AVIV, Israel, May 30, 2025 /PRNewswire/ -- BioLineRx Ltd ...